Navigation Links
Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
Date:2/20/2013

k faster and long-lasting wound healing solutions. Reacting to customer demand, manufacturers are adopting best practices to design wound dressings that provide tight control over the dressing's adsorption and fluid handling properties.

There is a surge in the number of wound healing technology platforms awaiting commercialization and multiple start-up firms and spin-offs from academia are working on procuring funds and partnerships for commercialization. Both Tier 1 and emerging companies are engaged in intense R&D to develop dressings that accelerate healing.

"Emerging companies that focus on every type of wound at each phase of the wound healing process will be able to provide innovative solutions," noted Frost & Sullivan Technical Insights Industry Analyst Prasanna Vadhana Kannan. "One of the noteworthy wound care solutions are advanced wound dressings that can assist in the complex task of tissue repair and efficiently remove bacterial biofilm formation."

Currently, there are no national or international standards to guide wound care dressing manufacturers, and the type of protocol adopted depends upon the physician's recommendation and patient's demand. This situation hinders the implementation and testing of affordable wound care platforms.

Standardization is vital since wound treatment relies heavily on proper wound bed preparation, the choice of wound dressings, and the patient's condition. Wound closure also depends on the use of appropriate products.

Researchers are striving to examine the importance of cell differentiation and tissue morphogenesis-based factors in faster wound healing. Manufacturers need greater clinical evidence to understand biological-mediated therapies and their role in improving the outcome of wound care.

"On the back of considerable research, wound care solutions are expected to have the capabilities to safeguard cells from apoptosis, and simultaneously stimulate rapid cell division
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lentigen Receives U.S. Orphan Drug Designation for Novel Gene Therapy for glioblastoma multiforme
2. Novelos Therapeutics Prices $5.5 Million Public Offering
3. Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempras Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model
4. RQx Pharmaceuticals and Genentech Enter Drug Discovery Collaboration to Develop Novel Drug Compounds
5. Frost & Sullivan Determines a Real and Urgent Need for Novel Cancer Diagnostics Tests
6. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
7. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
8. Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 2015
9. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
10. Insero Health Completes Phase I Trial of Novel Therapy in Patients With Drug Resistant Epilepsy
11. ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014  Hologic, Inc. (NASDAQ: ... Hologic,s President and Chief Executive Officer, will preside over ... 1, the first day of Breast Cancer Awareness Month. ... campaign focused on the important benefits of Hologic,s 3D ... FDA as clinically superior to traditional mammography. ...
(Date:9/30/2014)... 2014  Tasly Pharmaceuticals, Inc., the world,s leader ... today the launch of Deepure. Deepure ... men and women concerned with supporting their overall ... age while helping keep their health care cost ... herb-based formulas, namely, ProHeart PLUS, ImmunoPower PLUS, and ...
(Date:9/30/2014)... 30, 2014 STUDY OBJECTIVES The ... to provide an overview of the current and ... drugs/therapeutics. The key objective is to present a ... as an important tool in the treatment of ... future strategies within the protein therapeutics market, which ...
Breaking Medicine Technology:Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 2Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 3Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 4
... 13 Dynatronics Corporation (Nasdaq: DYNT ) today announced ... , Net income for the fiscal first quarter was $68,625 ... ($.01 per share) for the comparable prior year period. Sales ... $7,996,149 for the first quarter of the prior fiscal year. ...
... Eli Lilly and Company (NYSE: LLY ) announced ... science and technology, and president, Lilly Research Laboratories, will ... also announced that Jan M. Lundberg, Ph.D., executive vice ... to become his successor. Paul is committed to working ...
Cached Medicine Technology:Dynatronics Announces Positive Financial Results for Quarter 2Dynatronics Announces Positive Financial Results for Quarter 3Dynatronics Announces Positive Financial Results for Quarter 4Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor 2Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor 3
(Date:10/1/2014)... (PRWEB) October 01, 2014 Phoseon Technology, ... , continues to expand the business worldwide. This rapid ... with additional capacity for manufacturing efforts. The company has ... last five years and expects this growth to continue ... curing technology gains worldwide adoption. , “We are ...
(Date:10/1/2014)... 01, 2014 Beverly Hills licensed Clinical ... is celebrating 20 years of private practice in her ... people to achieve greater joy and fulfillment in their ... warning signs and suggestions for anyone who suspects they ... “Believe it or not, it’s not always easy ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Anti Aging ... and skin rejuvenating destination of choice, is announcing a ... October through to December. , “We’re doing this because ... possible to our top skin clinic in Toronto,” says ... do so much at Anti Aging Clinic, including laser ...
(Date:10/1/2014)... October is national Breast Cancer Awareness Month—an annual ... raising money for breast cancer research. Pelican Water is ... in the effort to find a cure. , ... having access to clean, healthy water. Research has shown ... forms of cancer. , The Problem of Chlorine ...
(Date:10/1/2014)... Washington, DC (PRWEB) October 01, 2014 ... of all retail generics increasing in price in the ... Information Services, Inc.’s (AIS) Drug Benefit News (DBN) interviewed ... this trend means for pharmacies and health plans. ... pace with rising generic acquisition costs, these cost increases ...
Breaking Medicine News(10 mins):Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 2Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 3
... the U.S. and Canada have been selected to participate ... initiative in immunotherapy funded by the National Cancer Institute ... will establish a network of top academic immunologists to ... patients, own immune systems to fight their cancer. , ...
... , WEDNESDAY, April 6 (HealthDay News) -- Poor ... have the condition diagnosed, but this disparity has decreased in ... data on children in California and found that the average ... born in 1992 to 3.8 years for those born in ...
... the April 5 White House Press Briefing, President Barack Obama ... in Congress from both political parties in order to avoid ... he has matched the initial House of Representatives, proposal to ... only in areas of priority. He expressed that neither side ...
... neonatal horse can be a challenging patient. Its immune system is ... like most infants it wants to stay close to mom. ... Pamela Wilkins , a professor of equine internal medicine and ... a new paper on equine neonatal intensive care. The ...
... to find such high levels of PCBs, highly toxic compounds ... a region such as the western coast of Africa", Ailette ... (UPV/EHU-Spain) and co-author of a study published in the journal ... which some studies have shown to be carcinogenic compounds, were ...
... over, newts and salamanders. The mouse may join you as ... Researchers are reporting that a simple chemical cocktail can coax ... in the first stages of a regenerating limb. Their study, ... the biological raw material for a new limb, appears in ...
Cached Medicine News:Health News:Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network 2Health News:Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network 3Health News:Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network 4Health News:Autism Diagnoses Still More Likely in Richer Neighborhoods 2Health News:AADR applauds President Obama's support for maintaining biomedical research in FY11 2Health News:Treating newborn horses: A unique form of pediatrics 2Health News:Treating newborn horses: A unique form of pediatrics 3Health News:High levels of toxic compounds found on coasts of West Africa 2
... AFP IRMA,is an immunoradiometric assay ... (AFP) in serum. It is,intended ... in either of,two contexts:, (a) ... the,management of patients with,nonseminomatous testicular ...
Coat-A-Count PAP IRMA,is an immunoradiometric assay designed,for the quantitative measurement of,prostatic acid phosphatase (PAP) in,serum. It is intended strictly for in vitro,diagnostic u...
The MOSAIC PET scanner is designed to meet the exacting requirements of animal research imaging. Supported by proven Philips technology, MOSAIC provides a leading edge PET solution for reliable in-vi...
... EEG recording is assured even in the ... has high performance, high sensitivity amplifiers, high ... filter, shielded electrodes and a high performance ... is a complete and ready to ...
Medicine Products: